Results 51 to 60 of about 27,467 (180)

Carcinomatosis meningítica metastatizada

open access: yes, 2009
Cuatro imágenes de una carcinomatosis meningítica metastatizada en un paciente de 74 años.Four pictures of a metastasized meningitic carcinomatosis in a 74-year-old male ...
Iglesias Rozas, José Rafael, 1942-
core  

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

open access: yesInternational Journal of Cancer, Volume 159, Issue 7, Page 1735-1749, 1 October 2026.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg   +9 more
wiley   +1 more source

Long-term results and prognostic factors of gastric cancer patients with microscopic peritoneal carcinomatosis. [PDF]

open access: yes, 2012
BACKGROUND: Clinical significance of microscopic peritoneal carcinomatosis remained unclear. The aim of this study was to evaluate the prognostic value of microscopic peritoneal carcinomatosis in gastric cancer.
Wang Yanong   +7 more
core   +1 more source

Diagnostic and therapeutic strategies in peritoneal carcinomatosis from breast cancer – literature minireview

open access: yes, 2018
Peritoneal carcinomatosis with breast cancer origin is an uncommon situation, which usually develops late during the evolution of the disease. The development of such lesions is commonly associated with an aggressive histology (such as lobular carcinoma)
Alin BODOG   +5 more
core   +1 more source

Fluorescent Nanoparticles for the Guided Surgery of Ovarian Peritoneal Carcinomatosis

open access: yes, 2018
International audienceComplete surgical resection is the ideal cure for ovarian peritoneal carcinomatosis, but remains challenging. Fluorescent guided surgery can be a promising approach for precise cytoreduction when appropriate fluorophore is used.
Marchal, Frédéric   +20 more
core   +1 more source

Rationale for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis

open access: yes, 2004
peer reviewedUp to now, the prognosis of peritoneal carcinomatosis from GI tract cancers remains very poor. Intraperitoneal hyperthermic chemotherapy has been proposed in the prevention or treatment of peritoneal carcinomatosis.
Honore, Pierre   +5 more
core   +1 more source

Comparison of experimental mouse models of colorectal peritoneal carcinomatosis

open access: yes, 2018
International audienceAnimal cancer models play an important role to study the development and progression of peritoneal carcinomatosis and to assess new treatments The aim of this study was to compare 4 mouse models of colorectal peritoneal ...
Bardet, Sylvia, M.   +4 more
core   +1 more source

A rare presentation of Pulmonary Lymphangitic Carcinomatosis in cancer of lip: case report [PDF]

open access: yes, 2011
Squamous cell carcinoma of lip is a common malignancy in Indian subcontinent. Metastatic spread is infrequent. Although advanced tumours spread to lymph nodes in the neck, it does not typically present with lung metastasis or with lymphangitic ...
M Geetha   +7 more
core   +1 more source

Carcinomatosis matters: clinical outcomes and prognostic factors for clinical success of stent placement in malignant gastric outlet obstruction.

open access: yes, 2014
BACKGROUND: Although carcinomatosis is not a contraindication to stenting in selected patients with malignant gastric outlet obstruction (GOO), associate factors for clinical success rate of self-expandable metallic stent (SEMS) placement in GOO patients
박찬혁   +8 more
core   +1 more source

Looking up: Recent advances in understanding and treating peritoneal carcinomatosis

open access: yes, 2016
Until recently, a diagnosis of peritoneal carcinomatosis was uniformly accompanied by a grim prognosis that was typically measured in weeks to months. Consequently, the management of carcinomatosis revolves largely around palliation of symptoms such as ...
Lambert, Laura A.
core   +1 more source

Home - About - Disclaimer - Privacy